KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Share-based Compensation (2017 - 2025)

Historic Share-based Compensation for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $42.8 million.

  • Guardant Health's Share-based Compensation fell 1398.66% to $42.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $159.4 million, marking a year-over-year increase of 2417.17%. This contributed to the annual value of $140.4 million for FY2024, which is 5470.75% up from last year.
  • According to the latest figures from Q3 2025, Guardant Health's Share-based Compensation is $42.8 million, which was down 1398.66% from $42.5 million recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Share-based Compensation peaked at $55.1 million during Q1 2021, and registered a low of $20.6 million during Q3 2022.
  • Over the past 5 years, Guardant Health's median Share-based Compensation value was $27.0 million (recorded in 2024), while the average stood at $31.6 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 76887.03% in 2021, then tumbled by 5496.74% in 2022.
  • Guardant Health's Share-based Compensation (Quarter) stood at $26.9 million in 2021, then fell by 11.74% to $23.7 million in 2022, then grew by 2.6% to $24.3 million in 2023, then skyrocketed by 49.53% to $36.4 million in 2024, then rose by 17.71% to $42.8 million in 2025.
  • Its Share-based Compensation was $42.8 million in Q3 2025, compared to $42.5 million in Q2 2025 and $37.8 million in Q1 2025.